• The Role of Virtual Twins in Clinical Trials

    Jul 13 | Clinical Research News | Right now—in the midst of a pandemic that is impacting everything from engineering to healthcare—there are great opportunities for virtual models. More
  • Robust Controlled Human Infection Models Still 2 Years Out, Other COVID-19 News

    Jul 10 | Clinical Research News | It could take up to two years to develop robust controlled human infection models for SARS-CoV-2 that meet essential criteria for limiting risk for study volunteers, according to a recent report in the New England Journal of Medicine. This, plus more, is included in this week’s announcements and updates from the clinical research industry. More
  • Patient Influencers Becoming Voices Of the Patients

    Jul 08 | Clinical Research News | Patient influencers have been a growing trend in the patient advocacy space, serving as mediators between clinical researchers and the patients they hope to treat. More
  • A Deep Dive Into Protocol Adherence Within Clinical Trials

    Jul 07 | Clinical Research News | While adherence in clinical research may seem straightforward, analysis conducted by AiCure shows that the issue of adherence—or more accurately non-adherence—can take many forms. More
  • New Data Shed Light On T-Cell Response To COVID-19, Other News

    Jul 02 | Clinical Research News | New data shed light on the potential variations in T-cell responses as a function of disease severity, an issue that is key to understanding the potential role of immunopathology in COVID-19, and also inform vaccine design and evaluation. Meanwhile, universities are continuing to build out their telehealth capabilities in light of the pandemic. This, plus more, are included in this week’s announcements and updates from the clinical research industry. More
  • Could Plasma Dilution Be The Answer To Age-Related Diseases—and Cytokine Storm?

    Jun 29 | Clinical Research News | Therapeutic plasma exchange, a 30-year-old clinical procedure, could explode in popularity if its mouse equivalent holds true in humans—reduction in damaging proteins that have been implicated in diseases such as Alzheimer’s disease and heart failure. More
  • Socioeconomic Status May Determine COVID-19’s Impact, Other News and Updates

    Jun 26 | Clinical Research News | New research indicates that COVID-19 disproportionately affects those of lower socioeconomic status and greater household crowding. Meanwhile, companies are forming a crowd-sourcing initiative to jump start COVID-19 data collection. This, plus more, are included in this week’s announcements and updates from the clinical research industry. More
  • Dynatrace, Seven Bridges, Trialbee, And More: News From June 2020

    Jun 25 | Clinical Research News | June was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Dynatrace, Seven Bridges, Trialbee, and more. More
  • The Potential Of Activity Trackers To Bias Study Results

    Jun 23 | Clinical Research News Contributed Commentary | Blinding data to remove bias is a fundamental principle of randomized controlled trials (RCTs). Does the advent of smartwatches, fitness trackers and other wearable technology and health apps mean that steps should no longer be used as an endpoint in RCTs? More
  • EHRs + Machine Learning Decipher Drug Effects In Pregnant Persons

    Jun 22 | Clinical Research News | Researchers at Vanderbilt University Medical Center are using a novel, data-driven “target trial” framework to investigate the efficacy and safety of medicines in pregnant populations, who are underrepresented in randomized controlled trials. More
View more articles
The DIA 2020 Global Annual Meeting is more than a meeting: it's an experience focused on the future of health. Spanning the life sciences spectrum, DIA 2020 will compile more than 250 sessions over 13 unique tracks with nine various learning formats, ensuring each attendee has the best learning opportunities.

Affiliated Reports Collection
Patient-centric pharma - Advancing the new business model  reveals how success can be achieved and provides food for thought on various ways to place patients firmly at the heart of your business and achieve commercially beneficial outcomes.